Stefan Bielack

32.5k total citations · 7 hit papers
215 papers, 14.0k citations indexed

About

Stefan Bielack is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Oncology. According to data from OpenAlex, Stefan Bielack has authored 215 papers receiving a total of 14.0k indexed citations (citations by other indexed papers that have themselves been cited), including 167 papers in Pulmonary and Respiratory Medicine, 71 papers in Rheumatology and 61 papers in Oncology. Recurrent topics in Stefan Bielack's work include Sarcoma Diagnosis and Treatment (158 papers), Bone Tumor Diagnosis and Treatments (63 papers) and Cardiac tumors and thrombi (30 papers). Stefan Bielack is often cited by papers focused on Sarcoma Diagnosis and Treatment (158 papers), Bone Tumor Diagnosis and Treatments (63 papers) and Cardiac tumors and thrombi (30 papers). Stefan Bielack collaborates with scholars based in Germany, Austria and Switzerland. Stefan Bielack's co-authors include J. Ritter, Heribert Jürgens, Richard Görlick, R. Kotz, Paul S. Meltzer, Michael S. Isakoff, Beate Kempf‐Bielack, A. Zoubek, D. Carrle and Winfried Winkelmann and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Stefan Bielack

211 papers receiving 13.8k citations

Hit Papers

Prognostic Factors in High-Grade Osteosarcoma of the Extr... 2002 2026 2010 2018 2002 2002 2015 2010 2003 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
    2002 1.6k citations Stefan Bielack Journal of Clinical Oncology profile →
  2. Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
    2002 1.4k citations Stefan Bielack, Beate Kempf‐Bielack et al. Journal of Clinical Oncology profile →
  3. Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
    2015 1.2k citations Stefan Bielack, Richard Görlick et al. Journal of Clinical Oncology profile →
  4. Osteosarcoma
    2010 793 citations Stefan Bielack et al. profile →
  5. Primary Metastatic Osteosarcoma: Presentation and Outcome of Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
    2003 649 citations Leo Kager, A. Zoubek et al. Journal of Clinical Oncology profile →
  6. Osteosarcoma
    2022 337 citations Hannah C. Beird, Stefan Bielack et al. Nature Reviews Disease Primers profile →
  7. Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE)
    2021 138 citations Andrea Ferrari, Dan Stark et al. ESMO Open profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefan Bielack Germany 52 8.6k 4.1k 3.8k 3.8k 2.6k 215 14.0k
Paul A. Meyers United States 66 9.0k 1.0× 4.2k 1.0× 3.3k 0.9× 4.2k 1.1× 1.8k 0.7× 262 15.7k
Francis J. Hornicek United States 71 9.2k 1.1× 4.6k 1.1× 6.8k 1.8× 4.6k 1.2× 2.4k 0.9× 453 19.4k
Heribert Jürgens Germany 48 7.5k 0.9× 2.3k 0.6× 3.0k 0.8× 3.2k 0.8× 1.2k 0.4× 186 11.9k
Stefano Ferrari Italy 56 7.3k 0.9× 2.0k 0.5× 3.5k 0.9× 2.8k 0.7× 1.2k 0.5× 206 10.0k
Brian P. Rubin United States 67 11.1k 1.3× 3.6k 0.9× 3.7k 1.0× 4.2k 1.1× 1.4k 0.5× 275 19.2k
Silvana Pilotti Italy 68 5.3k 0.6× 5.1k 1.3× 2.3k 0.6× 6.6k 1.7× 2.7k 1.0× 294 16.2k
Raphael E. Pollock United States 74 11.3k 1.3× 2.7k 0.7× 3.9k 1.0× 7.9k 2.1× 1.9k 0.7× 369 18.7k
Alberto S. Pappo United States 60 6.7k 0.8× 2.4k 0.6× 2.0k 0.5× 4.2k 1.1× 1.1k 0.4× 308 11.6k
G. Petur Nielsen United States 59 5.1k 0.6× 1.9k 0.5× 4.2k 1.1× 2.8k 0.7× 862 0.3× 221 10.3k
Antonio R. Pérez‐Atayde United States 63 4.2k 0.5× 5.8k 1.4× 2.8k 0.7× 3.2k 0.8× 1.3k 0.5× 297 17.4k

Countries citing papers authored by Stefan Bielack

Since Specialization
Citations

This map shows the geographic impact of Stefan Bielack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Bielack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Bielack more than expected).

Fields of papers citing papers by Stefan Bielack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Bielack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Bielack. The network helps show where Stefan Bielack may publish in the future.

Co-authorship network of co-authors of Stefan Bielack

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Bielack. A scholar is included among the top collaborators of Stefan Bielack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Bielack. Stefan Bielack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bielack, Stefan, Daniel Baumhoer, Andreas Beilken, et al.. (2025). Teleangiectatic Osteosarcoma Treated by Surgery and Chemotherapy: A Report of 223 Affected Patients From the Cooperative Osteosarcoma Study Group ( COSS ). Cancer Medicine. 14(17). e71211–e71211. 1 indexed citations
2.
Saloustros, Emmanouil, Andrea Ferrari, Nathalie Gaspar, et al.. (2024). An assessment of the attitudes, knowledge, and education regarding the health care needs of LGBTQ patients with cancer: results of an ESMO/SIOPE global survey. ESMO Open. 9(8). 103618–103618. 1 indexed citations
3.
Bielack, Stefan, Leo Kager, Thomas Kühne, et al.. (2023). Establishment, Maintenance, and Performance of the Cooperative Osteosarcoma Study Group (COSS). Cancers. 15(5). 1520–1520. 7 indexed citations
4.
Blattmann, Claudia, Stefan Bielack, Leo Kager, et al.. (2022). Secondary malignant neoplasms after bone and soft tissue sarcomas in children, adolescents, and young adults. Cancer. 128(9). 1787–1800. 11 indexed citations
5.
Hecker‐Nolting, Stefanie, Leo Kager, Thomas Kühne, et al.. (2022). Ultra-Late Osteosarcoma Recurrences: An Analysis of 17 Cooperative Osteosarcoma Study Group Patients with a First Recurrence Detected More Than 10 Years After Primary Tumor Diagnosis. Journal of Adolescent and Young Adult Oncology. 12(1). 76–82. 2 indexed citations
6.
Beird, Hannah C., Stefan Bielack, Adrienne M. Flanagan, et al.. (2022). Osteosarcoma. Nature Reviews Disease Primers. 8(1). 77–77. 337 indexed citations breakdown →
7.
Beird, Hannah C., Stefan Bielack, Adrienne M. Flanagan, et al.. (2022). Author Correction: Osteosarcoma. Nature Reviews Disease Primers. 8(1). 82–82. 7 indexed citations
8.
Meister, Michael T., Monika Scheer, Erika Hallmen, et al.. (2020). Malignant peripheral nerve sheath tumors in children, adolescents, and young adults: Treatment results of five Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry. Journal of Surgical Oncology. 122(7). 1337–1347. 7 indexed citations
9.
Sparber‐Sauer, Monika, Guido Seitz, Thekla von Kalle, et al.. (2018). Systemic therapy of aggressive fibromatosis in children and adolescents: Report of the Cooperative Weichteilsarkom Studiengruppe (CWS). Pediatric Blood & Cancer. 65(5). e26943–e26943. 17 indexed citations
10.
11.
Wilhelm, Miriam, Stefan Bielack, Katja Zils, et al.. (2013). Primary Pulmonary Metastatic Osteosarcoma: To Stop or Not to Stop, That is the Question. Journal of Adolescent and Young Adult Oncology. 2(1). 38–41. 4 indexed citations
12.
Dantonello, Tobias M., Andreas Schuck, Ingrid Kuehnle, et al.. (2012). Improved radiologic assessment of children with soft tissue sarcoma in the framework of the cooperative weichteilsarkom studiengruppe (CWS). Pediatric Blood & Cancer. 59(6). 977–977. 1 indexed citations
13.
Baumhoer, Daniel, Jan Smida, Katja Specht, et al.. (2011). Aberrant expression of the human epidermal growth factor receptor 2 oncogene is not a common feature in osteosarcoma. Human Pathology. 42(6). 859–866. 6 indexed citations
14.
Paulides, Marios, Wolfgang Stöhr, Hans‐Jürgen Laws, et al.. (2011). Antibody levels against tetanus and diphtheria after polychemotherapy for childhood sarcoma: A report from the Late Effects Surveillance System. Vaccine. 29(8). 1565–1568. 8 indexed citations
15.
Thomas, David M., Miriam Wilhelm, Anne‐Marie Cleton-Jansen, et al.. (2011). Workshop Report on the European Bone Sarcoma Networking Meeting: Integration of Clinical Trials with Tumor Biology. Journal of Adolescent and Young Adult Oncology. 1(3). 118–123. 1 indexed citations
16.
Dantonello, Tobias M., Ivo Leuschner, Andreas Schuck, et al.. (2010). SURVIVAL AFTER RECURRENCE OF METASTATIC RHAFIDOMYOSARCOMA - AN UNPROBABLE, BUT NOT IMPOSSIBLE EVENT IN THE EXPERIENCE OF THE COOPERATIVE WEICHTEILSARKOM STUDIENGRUPPE (CWS). Pediatric Blood & Cancer. 55(5). 900–901. 1 indexed citations
17.
Bielack, Stefan, Beate Kempf‐Bielack, D. Branscheid, et al.. (2008). Second and Subsequent Recurrences of Osteosarcoma: Presentation, Treatment, and Outcomes of 249 Consecutive Cooperative Osteosarcoma Study Group Patients. Journal of Clinical Oncology. 27(4). 557–565. 167 indexed citations
18.
19.
Grimer, R. J., Stefan Bielack, Silke Flege, et al.. (2005). Periosteal osteosarcoma – a European review of outcome. European Journal of Cancer. 41(18). 2806–2811. 53 indexed citations
20.
Ferrari, Stefano, Mario Mercuri, Gaetano Bacci, Stefan Bielack, & Heribert Jürgens. (2002). Comment on "prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols" [5] (multiple letters). Journal of Clinical Oncology. 20(12). 2910–2911. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul A. Meyers Breakdown of academic impact, for papers by Francis J. Hornicek Breakdown of academic impact, for papers by Heribert Jürgens Breakdown of academic impact, for papers by Stefano Ferrari Breakdown of academic impact, for papers by Brian P. Rubin Breakdown of academic impact, for papers by Silvana Pilotti Breakdown of academic impact, for papers by Raphael E. Pollock Breakdown of academic impact, for papers by Alberto S. Pappo Breakdown of academic impact, for papers by G. Petur Nielsen Breakdown of academic impact, for papers by Antonio R. Pérez‐Atayde
Rankless by CCL
2026